0001193125-26-059509
SEC filingCommunity Health Systems, Inc. (CYH) reported strong financial results for fiscal year 2025, ending December 31, 2025. The company generated $12.48 billion in net operating revenues, resulting in income from operations of $1.49 billion. After accounting for interest expense of $870 million, a gain from early extinguishment of debt of $97 million, and other items, net income attributable to CYH stockholders was $509 million, translating to earnings per share of $4.00 (both basic and diluted). The company's balance sheet shows total assets of $13.20 billion, but significant long-term debt of $10.38 billion contributes to a stockholders' deficit of $1.16 billion. Cash flow from operations was $543 million, while investing activities provided $847 million primarily from dispositions, and financing activities used $1.17 billion mainly for debt repayments. The company ended the year with $260 million in cash and cash equivalents.
Community Health Systems, Inc. delivered solid financial performance for fiscal year 2025 with $12.48 billion in net operating revenues. The company achieved income from operations of $1.49 billion, representing an operating margin of 11.9%. After accounting for interest expense of $870 million, gain from early extinguishment of debt of $97 million, equity earnings of $9 million, and income tax provision of $48 million, net income was $676 million. Of this, $509 million was attributable to CYH stockholders, resulting in earnings per share of $4.00 (both basic and diluted). The company's weighted-average shares outstanding were 133.6 million (basic) and 135.0 million (diluted).
The company reported net operating revenues of $12.48 billion for fiscal year 2025. No segment breakdown, geographic mix, or specific growth drivers were provided in the available data. The revenue figure represents the total consolidated operating revenues for the period ending December 31, 2025.
The company achieved an operating margin of 11.9% based on $1.49 billion in income from operations on $12.48 billion in revenues. Major operating expense components included salaries and benefits of $5.41 billion, supplies of $1.86 billion, other operating expenses of $3.42 billion, lease cost and rent of $277 million, depreciation and amortization of $426 million, and an impairment and gain on sale of businesses net of -$406 million, totaling $11.00 billion in operating expenses. The net income margin attributable to stockholders was 4.1% ($509 million / $12.48 billion).
Operating activities generated $543 million in cash flow, primarily from net income of $676 million adjusted for non-cash items including depreciation and amortization of $426 million, deferred income taxes of -$243 million, and impairment/gain adjustments of -$406 million. Investing activities provided $847 million, largely from $1.25 billion in proceeds from disposition of hospitals offset by $335 million in capital expenditures. Financing activities used $1.17 billion, with $6.52 billion in debt repayments partially offset by $5.49 billion in new borrowings. The balance sheet shows total assets of $13.20 billion, including $3.23 billion in current assets and $4.50 billion in net property and equipment. Total liabilities of $14.04 billion include $10.38 billion in long-term debt, resulting in stockholders' deficit of $1.16 billion.
No management guidance, strategic priorities, or specific risk factors were provided in the available data. The filing does not include forward-looking statements or outlook information in the provided content.